vaccine

Animal and human trials are promising, Dr. Anthony Fauci tells lawmakers Friday, and the government is preparing for widespread distribution once a vaccine is shown to be safe and effective.

The University of North Carolina is among the new sites for a COVID-19 vaccine trial. 

A survey by The Associated Press-NORC Center for Public Affairs Research finds 25% of black respondents plan to get a COVID-19 vaccine when one becomes available, compared to 56% of whites.

Developing and producing a vaccine is a complicated process — one that is heavily reliant on countries sharing supplies and a common goal, says Prashant Yadav of the Center for Global Development.

The race is on. What will it take to develop, test and distribute a safe and effective vaccine?

Noting that trials are still in the early phase, Dr. Anthony Fauci says the plan is to develop a vaccine that is safe and effective — and can be quickly scaled up for distribution.

The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.

There are definitely similarities between COVID-19, caused by the coronavirus, and influenza. But there are critical differences as well, including the death rate.

The government declared a state of emergency Friday. At least six people have died. Officials say most of them were children under two.